Latest News

Source:
Date range from to
Keyword:

Multiparametric MRI in prostate cancer

Cancerworld (EU) - 26/06/2017
This egrandround was first presented by Caroline Moore, from University College Hospital London, as a live webcast for the European School of Oncology. It is edited by Susan Mayor. The webcast of this and other e-grandrounds can be accessed at e-eso.net Until the last few years MRI was used essentially as a staging tool in prostate cancer, with imaging being performed after a biopsy to assess a patient’s suitability for radical treatment and for assessing extraprostatic extension and disease.

Popular prostate drug has negative impact on men's overall health, study suggests

News Medical (Australia) - 22/06/2017
Treatment of benign prostatic hyperplasia (BPH) with the commonly prescribed Avodart (Dutsteride) may put men at an increased risk for diabetes, elevated cholesterol levels, non-alcoholic fatty liver disease (NAFLD) and worsening erectile dysfunction.

Similarities between next-generation prostate cancer drugs discovered

Science Daily (US) - 22/06/2017
For the first time, researchers have shown how a class of advanced prostate cancer drugs are processed in the body and how their anti-tumor activity might change depending on how they are metabolized. Their pre-clinical findings may lay the foundation for improving therapies for treatment-resistant, aggressive prostate cancer.

Popular prostate drug linked to serious side effects

Science Daily (US) - 22/06/2017
Treatment of benign prostatic hyperplasia (BPH) with the commonly prescribed Avodart (Dutsteride) may put men at an increased risk for diabetes, elevated cholesterol levels, non-alcoholic fatty liver disease (NAFLD) and worsening erectile dysfunction, new research concludes.

Turmeric, red grape and apple can prevent prostate cancer

Daily Mail (UK) - 19/06/2017
Researchers from the University of Texas found eating the three ingredients in combination could help prevent prostate cancer. Prostate cancer affects one in eight men in the UK.

New three-in-one blood test opens door to precision medicine for prostate cancer

Science Daily (US) - 19/06/2017
Scientists have developed a three-in-one blood test that could transform treatment of advanced prostate cancer through use of precision drugs designed to target mutations in the BRCA genes. By testing cancer DNA in the bloodstream, researchers found they could pick out which men with advanced prostate cancer were likely to benefit from treatment with exciting new drugs called PARP inhibitors.

Prostate cancer blood test 'helps target treatment'

BBC Health News - 19/06/2017
By detecting cancer DNA in blood, the test can identify which men will benefit from precision drugs.

Blood test may show if prostate cancer treatment is working

NHS Choices (UK) - 19/06/2017
"Prostate cancer blood test helps target treatment," BBC News reports. A study found a blood test could detect which men with advanced prostate cancer would benefit from new drug treatment. Researchers analysed blood samples from nearly 50 men taking part in a trial of a new drug (olaparib) for prostate cancer that has spread to other parts of the body. They wanted to see whether changes to tumour DNA circulating in the men's blood could indicate whether the treatment was working or not. 

Blood test may show if prostate cancer treatment is working

Behind the Headlines (NHS, UK) - 19/06/2017
"Prostate cancer blood test helps target treatment," BBC News reports. A study found a blood test could detect which men with advanced prostate cancer would benefit from new drug treatment. Researchers analysed blood samples from nearly 50 men taking part in a trial of a new drug (olaparib) for prostate cancer that has spread to other parts of the body. They wanted to see whether changes to tumour DNA circulating in the men's blood could indicate whether the treatment was working or not. 

Smart blood test could cut prostate cancer death rate

Daily Mail (UK) - 16/06/2017
The test identifies prostate cancer patients with aggressive forms of the disease, whose risk of dying is ten times higher than men with slow-growing, relatively harmless tumours.

Blood cell discovery identifies patients with aggressive prostate cancer

Science Daily (US) - 15/06/2017
Patients who have aggressive prostate cancer could be identified by a highly accurate and simple blood test, according to an early study.

Two thirds of men unaware of family prostate cancer danger

Daily Mail (UK) - 13/06/2017
One in every eight British men will develop the disease in their lifetime, a figure that rises to one in four among black men. The cancer is easily dealt with if diagnosed early.

Moffitt researchers develop novel drug that may help combat castration-resistant prostate cancer

News Medical (Australia) - 13/06/2017
Prostate cancer is the third most common cause of cancer-related death in men in the United States. It is estimated that 161,360 men will be diagnosed and more than 26,700 men will die from the disease in this year.

Researchers identify inhibitor that overcomes drug resistance in prostate cancer

Science Daily (US) - 12/06/2017
A newly discovered epigenetic mechanism can lead to the development of castration-resistant prostate cancer, new research demonstrates.

Targeted photodynamic therapy shown highly effective against prostate cancer

Science Daily (US) - 12/06/2017
Researchers have demonstrated the efficacy and optimal dose for targeted photodynamic therapy (tPDT) to treat prostate cancer before and during surgery. Prostate-specific membrane antigen (PSMA) was targeted with an anti-PSMA antibody radiolabeled with the tracer indium-111 (111In) and coupled with specialized photosensitizers that cause cell destruction upon exposure to near-infrared (NIR).

New scan helps men avoid risky and painful prostate biopsy

Daily Mail (UK) - 11/06/2017
Men with suspected prostate cancer could be spared a painful biopsy procedure with a new scan instead, currently being studied at Southmead Hospital in north Bristol.

New diagnostic test uses machine learning to accurately detect aggressive prostate cancer

News Medical (Australia) - 09/06/2017
A new diagnostic developed by Alberta scientists will allow men to bypass painful biopsies to test for aggressive prostate cancer.

Research hints at why more blacks die of prostate cancer

Daily Mail (UK) - 08/06/2017
New US research points to a clue on why black men are twice as likely to die from prostate cancer than white men. The study found they were more worried about the cost and side effects.

Starving prostate cancer with what you eat: Apple peels, red grapes, turmeric

Science Daily (US) - 06/06/2017
When you dine on curry and baked apples, enjoy the fact that you are eating something that could play a role starving -- or even preventing -- cancer. New research identifies several natural compounds found in food, including turmeric, apple peels and red grapes, as key ingredients that could thwart the growth of prostate cancer.